본문 바로가기

Ellipticine induces apoptosis in human endometrial cancer cells: The potential involvement of reactive oxygen species and mitogen-activated protein kinases

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
TOXICOLOGY289(2-3) · pp.91 · 2011
피인용
Web of Science 53
JCR IF
JCR 2010 3.641
ISSN
0300-483X

저자

  1. Kim, Ji Young제1저자
  2. Lee, Seung Gee동아대학교, 의과대학, 의학과, KO
  3. Chung, Jin-Yong동아대학교, 의과대학, 의학과, KO
  4. Kim, Yoon-Jae동아대학교, 의과대학, 의학과, KO
  5. Park, Ji-Eun동아대학교, KO
  6. Koh, Hyungjong동아대학교, KO
  7. Han, Myoung Seok동아대학교, KO
  8. 박영철부산대학교, 의과대학, 의과학과, KO
  9. Yoo, Young Hyun교신저자
  10. Kim, Jong-Min동아대학교, 의과대학, 의학과, KO

초록

Ellipticine, an alkaloid isolated from Apocyanaceae plants, has been shown to exhibit antitumor activity in several human malignant tissues including breast, thyroid, and ovarian cancers. The antitumor activity of ellipticine is thought to be primarily mediated by the induction of DNA damage through the inhibition of topoisomerase II and formation of DNA adducts. The human endometrium is known to express topoisomerase II. However, the apoptogenic activity of ellipticine and the mechanisms underlying its action have not been investigated in endometrial cancer cells. In the present study, exposure to ellipticine (1-10 mu M) was shown to induce apoptosis in RL95-2 human endometrial cancer cells. Ellipticine-induced cell death was associated with the accumulation of cells in the G2/M phase of the cell cycle and was accompanied by depolarization of the mitochondrial membrane potential, release of cytochrome c and apoptosis-inducing factor (AIF) from the mitochondrial membrane, and caspase activation. The production of intracellular reactive oxygen species (ROS) was increased and sustained at high levels during ellipticine treatment. Subsequent to ROS accumulation, extracellular-signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) were activated in ellipticine-treated cells. Release of AIF from the mitochondria appeared to be affected by caspases, ROS, and ERK. The present data show that the treatment of RL95-2 cells with ellipticine induces apoptosis, ellipticine-induced apoptosis is mediated by ROS and the activation of MAPKs, and release of AIF is involved in a caspase-independent pathway. These results demonstrate the potential of ellipticine as a therapeutic strategy for the treatment of human endometrial cancers. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

키워드

EllipticineROSMAPKsMitochondriaApoptosisEndometrial cancer cellsANTICANCER DRUG ELLIPTICINEDNA ADDUCT FORMATIONARSENIC TRIOXIDECARCINOMA CELLSBREAST-CANCERCYCLE ARRESTDEATHPATHWAYSCHEMOTHERAPYMAPK

식별자

WoS UID
000295895400004